Croda Pharma wins prestigious “Best Supplier for COVID-19 Vaccine Development 2022” Award

6 May 2022

Croda, the company that uses smart science to improve lives, announces that it has been awarded winner a prestigious award for its work in supporting vaccine development. The company has been awarded “Best Supplier for COVID-19 Vaccine Development” at the India Biologics & Vaccines Outstanding Industry Awards (BVOIA) 2022. 

The awards give recognition to exceptional biologics and vaccine experts, organizations and technologies that facilitate vaccine R&D and biologics manufacturing excellence at enhanced speed, reduced cost, and superior quality. 

This comes closely after Croda Pharma and Avanti Polar Lipids have presented at the World Vaccines Congress, Washington DC, and 12th Annual Vaccines World Summit, India, on their collaboration and work supporting vaccines globally.  

The award was celebrated in person by the Croda teams. Christel Haugsted, Director, Supply Chain Management of Croda Denmark, said: 

“This is exactly what Croda is all about – working together and making a difference. A great achievement by our customers can only be possible with the help from dedicated commercial teams, working together with directly with the manufacturing sites – in this case Croda Denmark. I am very proud to be part of this recognition, not only from the vaccine industry but from our customers. We can all be proud!”

Croda is continuously increasing its offering in innovative vaccine adjuvant systems, high purity excipients and lipid systems in order to empower biologics delivery, and to support the supply of critical ingredients for vaccines. 

Most recently, Croda has been awarded a £15.9 million grant by the UK Government to expand its manufacturing facilities in Leek, Staffordshire, which will continue to enhance the development of high-purity lipid systems – essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.